Michael Molony is a biotechnology professional with over 28 years of experience in drug development and bio-manufacturing, ranging from discovery to commercialization in the disciplines of CMC, Analytical Development and Quality Control.
Michael has held the position Director of Analytical Development for ADCs at Ajinomoto Althea since July 2015.
Last Editorial Review: April 22, 2016
Copyright © 2016 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.